LNAI Stock Analysis: Buy, Sell, or Hold?
LNAI - Lunai Bioworks Inc. Common Stock
$2.13
-0.02 (-1.16%)
âŧ
5d:
-5.33%
30d:
-8.58%
90d:
-5.75%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 21, 2026
0d
Get Alerted When LNAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LNAI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LNAI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LNAI is currently trading at $2.13, which is considered slightly low relative to its 30-day fair value range of $2.12 to $2.58.
Technical Outlook: Technically, LNAI is in a strong uptrend. The price is currently testing key support at $2.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LNAI scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LNAI is in a strong uptrend. The price is currently testing key support at $2.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LNAI scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.12 -
$2.58
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (30/100)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.12 -
$2.58
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.10
Resistance Level
$2.47
Current Trend
Strong Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Share & Embed Analysis
Last updated: August 24, 2026 6:04 PM ET
Data refreshes hourly during market hours. Next update: 7:04 PM
Data refreshes hourly during market hours. Next update: 7:04 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$91 | 39 SELL |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 46 HOLD |